Expression of the calcium-binding protein, parvalbumin, in cultured cortical neurons using a HSV-1 vector system enhances NMDA neurotoxicity

Molecular Brain Research

Volumn 40, Issue 2, 1996, Pages 285-296

  Hartley, Dean M ^a,c   Neve, Rachael L ^b   Bryan, John ^a   Ullrey, Donna B ^a   Bak, Sun Y ^a   Lang, Phung ^a   Geller, Alfred I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Calcium; Cell culture; Cell death; Glutamate; Herpes; Neuron; Neurotoxicity; Parvalbumin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BETA GALACTOSIDE; CALCIUM BINDING PROTEIN; GLUTAMATE DECARBOXYLASE; N METHYL DEXTRO ASPARTIC ACID; PARVALBUMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; EXPRESSION VECTOR; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOCHEMISTRY; MARKER GENE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 0030249841     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00066-6     Document Type: Article

References (83)

1. Alexianu M.E., Ho B.K., Mohamed A.H., La Bella V., Smith R.G., Appel S.H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36:1994;846-858.
2. Andressen C., Blumcke I., Celio M.R. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res. 271:1993;181-208.
3. Araki T., Kato H., Liu X.H., Kogure K., Kato K., Itoyama Y. An immunohistochemical study of parvalbumin containing interneurons in the gerbil hippocampus after cerebral ischemia. Metabol. Brain Dis. 9:1994;225-234.
4. Bahr B.A., Neve R.L., Sharp J., Geller A.I., Lynch G. Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector. Mol. Brain Res. 26:1994;277-285.
5. Baimbridge K.G., Celio M.R., Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurol. Sci. 15:1992;303-308.
6. Baimbridge, K.G. and Miller, J.J., Calcium binding proteins and experimental models of epilepsy. In H.L. Haas and G. Buzsaki (Eds.), Synaptic Plasticity in the Hippocampus, Springer-Verlag, Berlin, 1988, pp. 169-172.
7. Battleman D.S., Geller A.I., Chao M.V. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J. Neurosci. 13:1993;941-951.
8. Benedikz E., Casaccia-Bonnefil P., Stelzer A., Bergold P.J. Hyperexcitability and cell loss in kainate-treated hippocampal slice cultures. Neuroreport. 5:1993;90-92.
9. Beneveniste H., Drejer J., Schousboe A., Diemer N. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
10. Best N., Mitchell J., Baimbridge K.G., Wheal H.V. Changes in parvalbumin-immunoreactive neurons in the rat hippocampus following a kainic acid lesion. Neurosci. Lett. 155:1993;1-6.
11. Bleakman D., Roback J.D., Wainer B.H., Miller R.J., Harrison N.L. Calcium homeostasis in rat septal neurons in tissue culture. Brain Res. 600:1993;257-267.
12. Brandt P., Neve R.L. Expression of plasma membrane calcium-pumping ATPase mRNAs in developing rat brain subregions: evidence for stage-specific expression. J. Neurochem. 59:1992;1566-1569.
13. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
14. Castillo M.B., Celio M.R., Andressen C., Gotzos V., Rulicke T., Berger M.C., Weber J., Berchtold M.W. Production and analysis of transgenic mice with ectopic expression of parvalbumin. Arch. Biochem. Biophys. 317:1995;292-298.
15. Celio M.R. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience. 35:1990;375-475.
16. Celio M.R., Heizmann C.W. Calcium-binding protein parvalbumin as a neuronal marker. Nature. 293:1981;300-302.
17. Chard P.S., Bleakman D., Christakos S., Fullmer C.S., Miller R.J. Calcium buffering properties of calbindin D28K and parvalbumin in rat sensory neurones. J. Physiol. 472:1993;341-357.
18. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
19. Choi D.W. Methods for antagonizing glutamate neurotoxicity. Cerebrovas. Brain Metabol. Rev. 2:1990;105-147.
20. Choi D.W. Cerebral hypoxia: Some new approaches and unanswered questions. J. Neurosci. 10:1990;2493-2501.
21. Choi, D.W. and Hartley, D.M., Calcium and glutamate-induced cortical neuronal death. In S.G. Waxman (Ed.), Molecular and Cellular Approaches to the Treatment of Brain Disease, Raven Press, New York, 1993, pp. 23-34.
22. Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
23. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Ann. Rev. Neurosci. 13:1990;171-182.
24. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
25. del Rio J.A., de Lecea L., Ferrer I., Soriano E. The development of parvalbumin-immunoreactivity in the neocortex of the mouse. Brain Res. 81:1994;247-259.
26. Epstein P., Means A.R., Berchtold M.W. Isolation of a rat parvalbumin gene and full length cDNA. J. Biol. Chem. 261:1986;5886-5891.
27. Federoff H.J., Geschwind M.D., Geller A.I., Kessler J.A. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA. 89:1992;1636-1640.
28. Freund T.F., Buzsaki G., Leon A., Baimbridge K.G., Somogyi P. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp. Brain Res. 83:1990;55-66.
29. Freund T.F., Ylinen A., Miettinen R., Pitkanen A., Lahtinen H., Baimbridge K.G., Riekkinen P.J. Pattern of neuronal death in the rat hippocampus after status epilepticus, relationship to calcium binding protein content and ischemic vulnerability. Brain Res. Bull. 28:1991;27-38.
30. Geller A.I., Keyomarsi K., Bryan J., Pardee A.B. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. USA. 87:1990;8950-8954.
31. Gonzales C., Lin R.C.-S., Chesselet M.-F. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neurosci. Lett. 135:1992;53-58.
32. Goto S., Nagahiro S., Korematsu K., Ushio Y. Striatonigral involvement following transient focal cerebral ischemia in the rats: an immunohistochemical study on a reversible ischemia model. Acta Neuropathol. 85:1993;515-520.
33. Hartley D.M., Choi D.W. Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture. J. Pharmacol. Exp. Ther. 250:1989;752-758.
34. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J. Neurosci. 13:1993;1993-2000.
35. Hartley D.M., Monyer H., Choi D.W. 7-Chlorokynurenate blocks NMDA receptor-mediated neurotoxicity in murine cortical culture. Eur. J. Neurosci. 2:1990;291-295.
36. Heizmann C.W. Calcium signaling in the brain. Acta Neurobiol. Exp. 53:1993;15-23.
37. Heizmann C.W., Braun K. Changes in Ca2+-binding proteins in human neurodegenerative disorders. Trends Neurol. Sci. 15:1992;259-264.
38. Hendry S.H., Jones E.G., Emson P.C., Lawson D.E., Heizmann C.W., Streit P. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp. Brain Res. 76:1989;467-472.
39. Ho D.Y., Mocarski E.S., Sapolsky R.M. Altering central nervous system physiology with defective herpes simplex virus vector expressing the glucose transporter gene. Proc. Natl. Acad. Sci. USA. 90:1993;3655-3659.
40. Johansen F.F., Tonder N., Zimmer J., Baimbridge K.G., Diemer N.H. Short-term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemia. Neurosci. Lett. 120:1990;171-174.
41. Johnson P.A., Miyanohara A., Levine F., Cahill T., Friedmann T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:1992;2952-2965.
42. Johnson P.A., Wang M.J., Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68:1994;6347-6362.
43. Kaplitt M.G., Kwong A.D., Kleopoulos S.P., Mobbs C.V., Rabkin S.D., Pfaff D.W. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. Natl. Acad. Sci. USA. 91:1994;8979-8983.
44. Kawaguchi Y., Katsumara H., Kosaka T., Heizmann C.W., Hama K. Fast spiking cells in rat hippocampus (CA1 region) contain the calcium binding protein parvalbumin. Brain Res. 416:1987;369-374.
45. Klingman J.G., Hartley D.M., Choi D.W. Automated determination of excitatory amino acid neurotoxicity in cortical culture. J. Neurosci. Methods. 31:1990;47-51.
46. Koh J., Goldberg M.P., Hartley D.M., Choi D.W. Non-NMDA receptor-mediated neurotoxicity in cortical cultures. J. Neurosci. 10:1990;693-705.
47. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
48. Kohr G., Lambert C.E., Mody I. Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Exp. Brain Res. 85:1991;543-551.
49. 2+ overload. Brain Res. 528:1990;48-54.
50. Kwong A.D., Kruper J.A., Frenkel N. Herpes simplex virus viron host shutoff function. J. Virol. 62:1988;912-921.
51. Leranth C., Ribak C.E. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: a possible key to this region's resistance to epileptic damage. Exp. Brain Res. 85:1991;129-136.
52. Lowenstein D.H., Miles M.F., Hatam F., McCabe T. Up regulation of calbindin-D28K mRNA in the rat hippocampus following focal stimulation of the perforant path. Neuron. 6:1991;627-633.
53. Manev H. Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity. FASEB. 4:1990;2789-2797.
54. Marcoux, F.W., Goodrich, J.E., Probert, A.W. and Dominick, M.A., Ketamine prevents glutamate-induced calcium influx and ischemia nerve cell injury. In E.F. Domino and J. Kamenka (Eds.), Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology, NPP Books, Ann Arbor, 1988, pp. 735-746.
55. Mattson M.P., Guthrie P.B., Kater S.B. Intracellular messengers in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. Res. 21:1988;447-464.
56. Mattson M.P., Rychlik B., Chu C., Christakos S. Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28K in cultured hippocampal neurons. Neuron. 6:1991;41-51.
57. McGeoch J.D., Dolan A., Donald S., Brauer D.H.K. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acid Res. 14:1986;1727-1745.
58. Michaels R.L., Rothman S.M. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J. Neurosci. 10:1990;283-292.
59. Monyer H., Giffard R.G., Hartley D.M., Dugan L.L., Goldberg M.P., Choi D.W. Oxygen and glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin. Neuron. 8:1992;967-973.
60. Mueller B.K., Kabos P., Neurmann T., Belhage B., Kater S.B. Transfected parvalbumin alters calcium homeostasis in a cell line. Soc. Neurosci. Abst. 19:1993;1178.
61. Neve R.L., Selkoe D.J., Kurnit D.M., Kosik K.S. A cDNA for human microtubule-associated protein 2 epitope in the Alzheimer neurofibrillary tangle. Mol. Brain Res. 1:1986;193-196.
62. 2+-binding protein parvalbumin. Neurosci. Lett. 105:1989;263-268.
63. Olney, J.W., Excitotoxins: an overview. In K. Fuxe, P. Roberts and R. Schwarz (Eds.), Excitotoxins, Macmillan, London, 1983, pp. 82-96.
64. Ovadi J., Orosz F. Calmodulin and dynamics of interactions of cytosolic enzymes. Curr. Topics Cell Reg. 33:1992;105-126.
65. Pfyffer G.E., Bologa L., Herschkowitz N., Heizmann C.W. Parvalbumin, a neuronal protein in brain cell cultures. J. Neurochem. 43:1984;49-57.
66. Pfyffer G.E., Faivre-Bauman A., Tixier-Vidal A., Norman A.W., Heizmann C.W. Developmental and functional studies of parvalbumin and calbindin D28K in hypothalamic neurons grown in serum-free medium. J. Neurochem. 49:1987;442-451.
67. Plogmann D., Celio M.R. Intracellular concentration of parvalbumin in nerve cells. Brain Res. 600:1993;273-279.
68. Querido K., Lee S.M., Hovda D.A., Becker D.P. Fluid-percussion brain injury selectively destroys parvalbumin containing cells in rat parietal cortex. Soc. Neurosci. Abst. 19:1993;1878.
69. Reiner A., Medina L., Figueredo-Cardenas G., Anfinson S. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp. Neurol. 131:1995;239-250.
70. Rothman S.M., Thurston J.H., Hauhart R.E. Delayed neurotoxicity of excitatory amino acid in vitro. Neuroscience. 22:1987;471-480.
71. Scharfman H.E., Schwartzkroin P.A. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science. 246:1989;257-260.
72. Siesjo B.K. A new perspective on ischemic brain damage? Prog. Brain Res. 96:1993;1-9.
73. Siesjo B.K., Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metabol. 9:1989;127-140.
74. Sloviter R.S. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J. Comp. Neurol. 280:1989;183-196.
75. Spaete R.R., Frenkel N. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell. 30:1982;295-304.
76. Steinberg G.K., Yoon E.J., Kunis D.M., Sun G.H., Maier C.M., Grant G.A. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing. Neuroscience. 64:1995;99-107.
77. Tecoma E.S., Choi D.W. GABAergic neocortical neurons are resistant to NMDA receptor-mediated injury. Neurology. 39:1989;676-682.
78. Tortosa A., Ferrer I. Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischaemia: a qualitative and quantitative sequential study. Neuroscience. 55:1993;33-43.
79. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron. 11:1993;223-235.
80. 2+ chelators. J. Cereb. Blood Flow Metab. 14:1994;911-923.
81. Waldvogel H.J., Faull R.L.M., Williams M.N., Dragunow M. Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res. 546:1991;329-335.
82. Weiss J.H., Koh J., Baimbridge K.G., Choi D.W. Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro. Neurology. 40:1990;1288-1292.
83. Young, A.B., Role of excitotoxins in heredito-degenerative neurologic diseases. In S.G. Waxman (Ed.), Molecular and Cellular Approaches to the Treatment of Brain Disease, Raven Press, New York, 1993, pp. 23-34.